| ［1］ |
Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer[J]. Lancet, 2020, 396(10251): 635–648.
|
| ［2］ |
Shmatko A, Ghaffari Laleh N, Gerstung M, et al. Artificial intelligence in histopathology: enhancing cancer research and clinical oncology[J]. Nat Cancer, 2022, 3(9): 1026–1038.
|
| ［3］ |
Bera K, Schalper KA, Rimm DL, et al. Artificial intelligence in digital pathology-new tools for diagnosis and precision oncology[J]. Nat Rev Clin Oncol, 2019, 16(11): 703–715.
|
| ［4］ |
Chen D, Fu M, Chi L, et al. Prognostic and predictive value of a pathomics signature in gastric cancer[J]. Nat Commun, 2022, 13(1): 6903.
|
| ［5］ |
Ba W, Wang S, Shang M, et al. Assessment of deep learning assistance for the pathological diagnosis of gastric cancer[J]. Mod Pathol, 2022, 35(9): 1262–1268.
|
| ［6］ |
Han Z, Zhang Z, Yang X, et al. Development and interpretation of a pathomics-driven ensemble model for predicting the response to immunotherapy in gastric cancer[J]. J Immunother Cancer, 2024, 12(5): e008927.
|
| ［7］ |
Sexton RE, Al Hallak MN, Diab M, et al. Gastric cancer: A comprehensive review of current and future treatment strategies[J]. Cancer Metastasis Rev, 2020, 39(4): 1179–1203.
|
| ［8］ |
Moscalu M, Moscalu R, Dascălu CG, et al. Histopathological images analysis and predictive modeling implemented in digital pathology-current affairs and perspectives[J]. Diagnostics (Basel), 2023, 13(14): 2379.
|
| ［9］ |
Ibrahim A, Gamble P, Jaroensri R, et al. Artificial intelligence in digital breast pathology: techniques and applications[J]. Breast, 2020, 49: 267–273.
|
| ［10］ |
Jiang Y, Yang M, Wang S, et al. Emerging role of deep learning-based artificial intelligence in tumor pathology[J]. Cancer Commun (Lond), 2020, 40(4): 154–166.
|
| ［11］ |
Sobhani F, Robinson R, Hamidinekoo A, et al. Artificial intelligence and digital pathology: opportunities and implications for immuno-oncology[J]. Biochim Biophys Acta Rev Cancer, 2021, 1875(2): 188520.
|
| ［12］ |
Abe H, Kurose Y, Takahama S, et al. Development and multi-institutional validation of an artificial intelligence-based diagnostic system for gastric biopsy[J]. Cancer Sci, 2022, 113(10): 3608–3617.
|
| ［13］ |
Ajani JA, D'Amico TA, Bentrem DJ, et al. Gastric Cancer, Version 2. 2022, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2022, 20(2): 167–192.
|
| ［14］ |
Wong ANN, He Z, Leung KL, et al. Current developments of artificial intelligence in digital pathology and its future clinical applications in gastrointestinal cancers[J]. Cancers (Basel), 2022, 14(15): 3780.
|
| ［15］ |
Yoshida H, Kiyuna T. Requirements for implementation of artificial intelligence in the practice of gastrointestinal pathology[J]. World J Gastroenterol, 2021, 27(21): 2818–2833.
|
| ［16］ |
Swillens JEM, Nagtegaal ID, Engels S, et al. Pathologists’ first opinions on barriers and facilitators of computational pathology adoption in oncological pathology: An international study[J]. Oncogene, 2023, 42(38): 2816–2827.
|
| ［17］ |
Heo YJ, Lee T, Byeon SJ, et al. Digital image analysis in pathologist-selected regions of interest predicts survival more accurately than whole-slide analysis: A direct comparison study in 153 gastric carcinomas[J]. J Pathol Clin Res, 2021, 7(1): 42–51.
|
| ［18］ |
Peng C, Liu J, Yang G, et al. The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system[J]. J Gastroenterol, 2018, 53(5): 606–617.
|
| ［19］ |
Peng CW, Wang LW, Zeng WJ, et al. Evaluation of the staging systems for gastric cancer[J]. J Surg Oncol, 2013, 108(2): 93–105.
|
| ［20］ |
Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging[J]. CA Cancer J Clin, 2017, 67(2): 93–99.
|
| ［21］ |
Martínez-Reyes I, Chandel NS. Cancer metabolism: looking forward[J]. Nat Rev Cancer, 2021, 21(10): 669–680.
|
| ［22］ |
Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis[J]. Nat Med, 2013, 19(11): 1423–1437.
|
| ［23］ |
Kim EY, Abdul-Ghafar J, Chong Y, et al. Calculated tumor-associated neutrophils are associated with the tumor-stroma ratio and predict a poor prognosis in advanced gastric cancer[J]. Biomedicines, 2022, 10(3): 708.
|
| ［24］ |
Tian CF, Jing HY, Sinicrope FA, et al. Tumor microenvironment characteristics association with clinical outcome in patients with resected intestinal-type gastric cancer[J]. Oncologist, 2024, 29(10): e1280-e1290.
|
| ［25］ |
Xu Y, Yang Y, Cheng F, et al. A predictive model and rapid multi-dynamic algorithm developed based on tumor-stroma percentage in gastric cancer: A retrospective, observational study[J]. Gastroenterol Rep (Oxf), 2024, 12: goae083.
|
| ［26］ |
Kobayashi H, Enomoto A, Woods SL, et al. Cancer-associated fibroblasts in gastrointestinal cancer[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(5): 282–295.
|
| ［27］ |
Gu L, Ding D, Wei C, et al. Cancer-associated fibroblasts refine the classifications of gastric cancer with distinct prognosis and tumor microenvironment characteristics[J]. Front Oncol, 2023, 13: 1158863.
|
| ［28］ |
Grunberg N, Pevsner-Fischer M, Goshen-Lago T, et al. Cancer-associated fibroblasts promote aggressive gastric cancer phenotypes via heat shock factor 1-mediated secretion of extracellular vesicles[J]. Cancer Res, 2021, 81(7): 1639–1653.
|
| ［29］ |
Dou R, Han L, Yang C, et al. Upregulation of LINC00501 by H3K27 acetylation facilitates gastric cancer metastasis through activating epithelial-mesenchymal transition and angiogenesis[J]. Clin Transl Med, 2023, 13(10): e1432.
|
| ［30］ |
Uhlik MT, Liu J, Falcon BL, et al. Stromal-based signatures for the classification of gastric cancer[J]. Cancer Res, 2016, 76(9): 2573–2586.
|
| ［31］ |
Shitara K, Van Cutsem E, Bang YJ, et al. Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 phase 3 randomized clinical trial[J]. JAMA Oncol, 2020, 6(10): 1571–1580.
|
| ［32］ |
Tan Y, Feng LJ, Huang YH, et al. A comprehensive radiopathological nomogram for the prediction of pathological staging in gastric cancer using CT-derived and WSI-based features[J]. Transl Oncol, 2024, 40: 101864.
|
| ［33］ |
Xie Y, Sang Q, Da Q, et al. Improving diagnosis and outcome prediction of gastric cancer via multimodal learning using whole slide pathological images and gene expression[J]. Artif Intell Med, 2024, 152: 102871.
|
| ［34］ |
Song Z, Zou S, Zhou W, et al. Clinically applicable histopathological diagnosis system for gastric cancer detection using deep learning[J]. Nat Commun, 2020, 11(1): 4294.
|
| ［35］ |
Zeng D, Li M, Zhou R, et al. Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures[J]. Cancer Immunol Res, 2019, 7(5): 737–750.
|
| ［36］ |
Chen S, Zhang K, Hu J, et al. KaryoXpert: An accurate chromosome segmentation and classification framework for karyotyping analysis without training with manually labeled metaphase-image mask annotations[J]. Comput Biol Med, 2024, 177: 108601.
|
| ［37］ |
Baudoin NC, Bloomfield M. Karyotype aberrations in action: the evolution of cancer genomes and the tumor microenvironment[J]. Genes (Basel), 2021, 12(4): 558.
|
| ［38］ |
Zhang S, Yuan Z, Zhou X, et al. VENet: variational energy network for gland segmentation of pathological images and early gastric cancer diagnosis of whole slide images[J]. Comput Methods Programs Biomed, 2024, 250: 108178.
|
| ［39］ |
Bagheri V, Gholamin M, Mansouri A, et al. Establishment and characterization of chemotherapy-enriched sphere-forming cells with stemness phenotypes as a new cell line (BAG(50)) of gastric carcinoma[J]. Med Oncol, 2022, 39(12): 201.
|
| ［40］ |
Jang HJ, Lee A, Kang J, et al. Prediction of genetic alterations from gastric cancer histopathology images using a fully automated deep learning approach[J]. World J Gastroenterol, 2021, 27(44): 7687–7704.
|
| ［41］ |
Suzuki H, Yoshitaka T, Yoshio T, et al. Artificial intelligence for cancer detection of the upper gastrointestinal tract[J]. Dig Endosc, 2021, 33(2): 254–262.
|
| ［42］ |
van der Laak J, Litjens G, Ciompi F. Deep learning in histopathology: the path to the clinic[J]. Nat Med, 2021, 27(5): 775–784.
|
| ［43］ |
Huss R, Coupland SE. Software-assisted decision support in digital histopathology[J]. J Pathol, 2020, 250(5): 685–692.
|
| ［44］ |
Niazi MKK, Parwani AV, Gurcan MN. Digital pathology and artificial intelligence[J]. Lancet Oncol, 2019, 20(5): e253-e261.
|
| ［45］ |
Deng Y, Feng M, Jiang Y, et al. Development of pathological reconstructed high-resolution images using artificial intelligence based on whole slide image[J]. MedComm, 2020, 1(3): 410–417.
|
| ［46］ |
Collins GS, Dhiman P, Andaur Navarro CL, et al. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence[J]. BMJ Open, 2021, 11(7): e048008.
|
| ［47］ |
Shiri I, Maleki H, Hajianfar G, et al. Next-generation radiogenomics sequencing for prediction of EGFR and KRAS mutation status in NSCLC patients using multimodal imaging and machine learning algorithms[J]. Mol Imaging Biol, 2020, 22(4): 1132–1148.
|
| ［48］ |
Gui CP, Chen YH, Zhao HW, et al. Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: A discovery and validation study[J]. Lancet Digit Health, 2023, 5(8): e515-e524.
|
| ［49］ |
Shi JY, Wang X, Ding GY, et al. Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning[J]. Gut, 2021, 70(5): 951–961.
|
| ［50］ |
Ke J, Shen Y, Lu Y, et al. Mine local homogeneous representation by interaction information clustering with unsupervised learning in histopathology images[J]. Comput Methods Programs Biomed, 2023, 235: 107520.
|
| ［51］ |
Yan J, Wang X. Unsupervised and semi-supervised learning: the next frontier in machine learning for plant systems biology[J]. Plant J, 2022, 111(6): 1527–1538.
|
| ［52］ |
Yu G, Sun K, Xu C, et al. Accurate recognition of colorectal cancer with semi-supervised deep learning on pathological images[J]. Nat Commun, 2021, 12(1): 6311.
|
| ［53］ |
Chen Y, Mancini M, Zhu X, et al. Semi-supervised and unsupervised deep visual learning: A survey[J]. IEEE Trans Pattern Anal Mach Intell, 2024, 46(3): 1327–1347.
|
| ［54］ |
Tsuneki M, Kanavati F. Weakly supervised learning for poorly differentiated adenocarcinoma classification in gastric endoscopic submucosal dissection whole slide images[J]. Technol Cancer Res Treat, 2022, 21: 15330338221142674.
|
| ［55］ |
Shi J, Shu T, Wu K, et al. Masked hypergraph learning for weakly supervised histopathology whole slide image classification[J]. Comput Methods Programs Biomed, 2024, 253: 108237.
|
| ［56］ |
Jiao R, Zhang Y, Ding L, et al. Learning with limited annotations: A survey on deep semi-supervised learning for medical image segmentation[J]. Comput Biol Med, 2024, 169: 107840.
|
| ［57］ |
Iizuka O, Kanavati F, Kato K, et al. Deep learning models for histopathological classification of gastric and colonic epithelial tumours[J]. Sci Rep, 2020, 10(1): 1504.
|
| ［58］ |
Zheng Y, Jiang Z, Xie F, et al. Diagnostic Regions Attention Network (DRA-Net) for histopathology WSI recommendation and retrieval[J]. IEEE Trans Med Imaging, 2021, 40(3): 1090–1103.
|
| ［59］ |
Kann BH, Hosny A, Aerts H. Artificial intelligence for clinical oncology[J]. Cancer Cell, 2021, 39(7): 916–927.
|